berbamine has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Q; Dong, QH; Lv, QH; Wang, GY; Xu, RZ | 1 |
| Dong, QH; Lü, QH; Wang, GY; Xu, RZ; Zhang, JW | 1 |
2 other study(ies) available for berbamine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Berberine; Bisbenzimidazole; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; fas Receptor; Humans; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Mice, Nude; Plants, Medicinal; Time Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2009 |
Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation.
Topics: Alkaloids; Apoptosis; Benzylisoquinolines; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Enzyme Activation; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Membrane Potentials; Mitochondria, Liver | 2007 |